Observational epidemiological studies have reported associations between several hormonal, metabolic and inflammatory factors linked to obesity and endometrial cancer, including bioavailable testosterone, sex hormone-binding globulin (SHBG), oestradiol and fasting insulin [18–22]. Here, SHBG is linked to obesity due to melanocortin 4 receptor deficiency.